1. Correction to: Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients.
- Author
-
Bidar, Frank, Hamada, Sarah, Gossez, Morgane, Coudereau, Remy, Lopez, Jonathan, Cazalis, Marie-Angelique, Tardiveau, Claire, Brengel-Pesce, Karen, Mommert, Marine, Buisson, Marielle, Conti, Filippo, Rimmelé, Thomas, Lukaszewicz, Anne-Claire, Argaud, Laurent, Cour, Martin, Monneret, Guillaume, Venet, Fabienne, RICO Study Group, Pescarmona, Remi, and Garnier, Lorna
- Subjects
COVID-19 ,T cells ,INTERLEUKIN-7 ,CRITICALLY ill ,HUMAN beings - Abstract
RNA extracted from PBMCs of COVID-19 patients at day 0 and day 20 (n = 10) and healthy volunteers (HV, n = 10) was analyzed through NanoString technology. a Volcano plots of differentially expressed genes between patients sampled at D0 or at D20 and HV are showed. Reference 1 Bidar F, Hamada S, Gossez M, Coudereau R, Lopez J, Cazalis M-A, Tardiveau C, Brengel-Pesce K, Mommert M, Buisson M, Conti F, Rimmelé T, Lukaszewicz A-C, Argaud L, Cour M, Monneret G, Venet F. Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients, for the RICO study group. [Extracted from the article]
- Published
- 2022
- Full Text
- View/download PDF